{
"schemaVersion": 2,
"eyebrow": "Emergency medicine",
"title": "Acute Abdomen",
"summary": "Acute abdomen requires parallel resuscitation and diagnosis: identify patients with peritonitis, shock, obstruction, ischemia, or hemorrhage who need urgent surgical or procedural management, while using focused laboratory testing and imaging to distinguish operative disease from conditions appropriate for monitored conservative care.",
"seoDescription": "Point-of-care evaluation of acute abdomen: triage instability, target testing and imaging, provide analgesia, and expedite surgical consultation.",
"clinicalQuestion": "How should clinicians rapidly identify, investigate, and manage acute abdominal presentations requiring urgent intervention?",
"specialty": "Emergency Medicine and General Surgery",
"audience": "U.S. physicians and medical trainees",
"tags": [
"acute abdomen",
"acute abdominal pain",
"surgical abdomen",
"abdominal emergency",
"peritonitis",
"abdominal imaging",
"emergency general surgery"
],
"keyTakeaways": [
"Acute abdomen is a time-sensitive syndrome; immediate assessment should distinguish patients needing urgent operative intervention from those suitable for conservative management.[12]",
"Severe, unremitting symptoms warrant thorough investigation and close monitoring because patients with surgical pathology may deteriorate rapidly.[12]",
"Analgesia should not be withheld for diagnostic uncertainty: opioid analgesia improves comfort without increasing diagnostic or treatment-decision errors in adults with acute abdominal pain.[12]",
"Older, immunocompromised, and pregnant patients may have atypical symptoms or blunted peritoneal signs; use a lower threshold for admission and cross-sectional imaging in immunocompromised patients.[12]"
],
"sections": [
{
"id": "immediate-triage",
"eyebrow": "First priority",
"heading": "Identify time-critical abdominal emergencies",
"intro": "Treat physiologic instability and diagnostic uncertainty concurrently.",
"paragraphs": [
"Acute abdomen denotes rapidly developing severe symptoms from abdominal pathology that may represent life-threatening disease requiring urgent surgical intervention.[12] The initial task is not to establish a complete differential diagnosis, but to recognize shock, peritonitis, hemorrhage, obstruction, ischemia, or evolving organ failure that requires immediate resuscitation and early surgical involvement.[12][16]",
"A surgical process may deteriorate quickly. Severe, persistent symptoms warrant close observation and thorough investigation even when early findings are nondiagnostic.[12] Physical examination and clinical context remain central; imaging supplements rather than replaces a careful history and examination.[16]"
],
"bullets": [
"Escalate immediately for hemodynamic instability, generalized peritoneal findings, progressive abdominal distention with obstructive features, or concern for intra-abdominal hemorrhage, perforation, bowel ischemia, or sepsis.[12][16]",
"Obtain early surgical consultation when an urgent surgical process is suspected; diagnostic laparoscopy may be considered in selected patients with unresolved acute abdominal pathology.[12]",
"Use serial examinations when the diagnosis remains uncertain or symptoms evolve; this is particularly important when initial testing does not explain persistent severe pain.[12]"
],
"subsections": [],
"table": {
"caption": "Initial priorities in suspected acute abdomen.[12][16]",
"columns": [
"Clinical priority",
"Action",
"Reason"
],
"rows": [
[
"Physiologic stabilization",
"Assess hemodynamics and monitor closely; prioritize resuscitation and urgent specialist evaluation when unstable.[12]",
"Instability may reflect life-threatening abdominal pathology requiring urgent intervention.[12]"
],
[
"Focused diagnostic assessment",
"Integrate history, examination, laboratory results, and imaging rather than relying on any single modality.[12]",
"Acute abdomen is diagnosed from the combined clinical and diagnostic assessment.[12]"
],
[
"Reassessment",
"Repeat examination and reassess trajectory when symptoms are severe or unresolved.[12]",
"Surgical pathology can deteriorate rapidly and may not be fully evident initially.[12]"
]
]
}
},
{
"id": "diagnostic-approach",
"eyebrow": "Diagnostic strategy",
"heading": "Use focused testing to answer the operative question",
"intro": "Order tests that identify a mechanism requiring immediate intervention.",
"paragraphs": [
"The diagnostic workup should be directed by pain location, associated symptoms, physiologic status, examination findings, pregnancy potential, comorbidity, and the suspected mechanism. For example, pregnancy testing is important in patients with lower abdominal pain, and pancreatic enzyme testing is useful when acute pancreatitis is suspected.[16] Basic blood counts may identify neutrophilia or anemia; renal function and electrolytes affect resuscitation and operative planning.[16]",
"Imaging is integral to triage and can help separate patients requiring immediate surgery from those appropriate for conservative treatment or less urgent intervention.[16] Cross-sectional imaging should be used with a lower threshold in immunocompromised patients because symptoms and examination findings may be nonspecific or inconclusive.[12]"
],
"bullets": [
"Use laboratory studies to define physiologic derangement and test disease-specific hypotheses; do not use isolated laboratory abnormalities to exclude serious abdominal pathology.[16]",
"In patients with suspected acute pancreatitis, lipase remains elevated longer than amylase and is more specific for pancreatic pathology, although either enzyme can be elevated in nonpancreatic disease.[16]",
"For possible ectopic pregnancy, rapid urine hCG establishes pregnancy status; quantitative serum hCG and pelvic ultrasonography inform localization when ectopic pregnancy remains possible.[16]",
"Choose imaging by suspected pathology and patient factors. CT and ultrasonography are complementary diagnostic tools, but neither substitutes for clinical assessment.[16]"
],
"subsections": [
{
"heading": "When CT changes management",
"paragraphs": [
"For suspected acute left-sided diverticulitis with diagnostic uncertainty, abdominal and pelvic CT is the preferred modality because it confirms diverticulitis, identifies complications, and evaluates alternative causes of lower abdominal pain.[24] In the index episode, CT is particularly useful because complicated disease occurs most often at initial presentation and imaging may inform future care planning.[24]"
],
"bullets": [
"Red flags such as severe pain with high fever, rectal bleeding, obstructive features, peritonitis, or concern for malignancy should prompt evaluation in a setting with CT capability and surgical expertise.[24]",
"Oral and intravenous contrast are preferred when feasible for diverticulitis, although noncontrast CT has similar diagnostic utility in patients with poor renal function.[24]"
]
}
],
"table": null
},
{
"id": "analgesia-and-support",
"eyebrow": "Supportive care",
"heading": "Provide analgesia while evaluation proceeds",
"intro": "Pain treatment and diagnostic accuracy are not competing objectives.",
"paragraphs": [
"Adequate analgesia should be provided during evaluation of undifferentiated acute abdominal pain. A meta-analysis of randomized trials found that opioid analgesia improved patient comfort without increasing diagnostic error or treatment-decision error in adults with acute abdominal pain.[12]",
"Antiemetic therapy, fluid resuscitation, correction of major metabolic abnormalities, and organ-specific supportive care should be tailored to the suspected process and physiologic status. The supplied evidence supports the principle of adequate analgesia but does not provide a source-supported universal medication regimen or dosing scheme for undifferentiated acute abdomen.[12]"
],
"bullets": [
"Do not defer opioid analgesia solely to preserve examination findings.[12]",
"Continue serial examinations after analgesia; evolving focal tenderness, guarding, distention, or hemodynamic deterioration should change disposition and consultation urgency.[12]",
"Avoid treating symptom control as evidence that a dangerous diagnosis has been excluded; reassess persistent or recurrent pain in the context of the full clinical trajectory.[12]"
],
"subsections": [],
"table": null
},
{
"id": "special-populations",
"eyebrow": "Diagnostic modifiers",
"heading": "Lower the threshold for escalation in high-risk populations",
"intro": "Atypical presentation is a major source of delayed diagnosis.",
"paragraphs": [
"Older adults, pregnant patients, children, and immunocompromised patients may have atypical symptoms and signs of acute abdominal pathology.[12] In older adults, comorbidity, medications, altered pain perception, and impaired inflammatory responses can obscure classic presentations; in one cited study of perforated ulcer, only 21% of older patients had peritonitis.[12]",
"Pregnancy can alter symptom localization and blunt peritoneal signs through uterine enlargement and abdominal wall laxity. Mild physiologic leukocytosis also reduces the specificity of leukocytosis in pregnant patients with abdominal pain.[12]",
"Immunocompromised patients may have nonspecific pain and inconclusive examination findings because of altered inflammatory responses. A lower threshold for hospital admission and cross-sectional imaging is recommended in this population.[12]"
],
"bullets": [
"In pregnancy, pursue further laboratory testing, imaging, or serial examinations when clinical suspicion for intra-abdominal pathology remains high despite equivocal initial findings.[12]",
"In immunocompromised patients, include therapy-related and opportunistic etiologies; neutropenic enterocolitis may present with fever, neutropenia, and right iliac fossa pain 10 to 14 days after chemotherapy initiation.[12]",
"In pediatric patients, select imaging according to age and differential diagnosis; ultrasound is a radiation-free first-line modality for several common pediatric acute abdominal conditions.[19]"
],
"subsections": [],
"table": {
"caption": "High-risk groups with altered presentation.[12][19]",
"columns": [
"Population",
"Diagnostic concern",
"Practical implication"
],
"rows": [
[
"Older adults",
"Peritoneal signs and physiologic inflammatory responses may be muted.[12]",
"Do not rely on absence of classic peritonitis; broaden testing and observation when symptoms or risk factors are concerning.[12]"
],
[
"Pregnant patients",
"Anatomic displacement and physiologic leukocytosis reduce reliability of localization and leukocytosis.[12]",
"Use targeted laboratory tests, imaging, and serial examination when suspicion persists.[12]"
],
[
"Immunocompromised patients",
"Symptoms and examination may be nonspecific or inconclusive.[12]",
"Use a lower threshold for admission and cross-sectional imaging.[12]"
],
[
"Children",
"Differential diagnosis and optimal imaging vary substantially by age.[19]",
"Use age-specific diagnostic pathways and judicious imaging, often beginning with ultrasound.[19]"
]
]
}
},
{
"id": "common-decision-points",
"eyebrow": "Clinical application",
"heading": "Match disposition to disease severity and reliability of follow-up",
"intro": "Outpatient management is appropriate only after dangerous pathology is reasonably excluded.",
"paragraphs": [
"Selected patients with imaging-confirmed uncomplicated diverticulitis may be managed as outpatients when they are immunocompetent, have controlled comorbidities, tolerate oral intake, and have reliable support and follow-up.[24] High fever, poor oral intake, rectal bleeding, palpable rectal mass, or focal peritonitis with guarding generally warrant admission.[24]",
"For selected uncomplicated diverticulitis, initial management without antibiotics is supported by randomized evidence, but antibiotics remain appropriate in higher-risk patients with comorbidity, immunosuppression, or systemic infection.[24] This disease-specific example illustrates the broader acute abdomen principle: disposition depends on physiologic stability, complication risk, diagnostic confidence, capacity for follow-up, and the expected trajectory rather than diagnosis alone.[24]"
],
"bullets": [
"Do not apply outpatient evidence from carefully selected uncomplicated diverticulitis cohorts to patients with peritoneal signs, systemic illness, inability to tolerate intake, immunocompromise, or unreliable follow-up.[24]",
"Complicated diverticulitis with perforation, obstruction, abscess, or fistula generally requires surgical or interventional radiology management.[24]",
"When acute diverticulitis is the first complicated episode, colonoscopy is recommended after recovery if recent colonoscopy is absent, to assess for underlying malignancy.[24]"
],
"subsections": [],
"table": null
}
],
"faq": [
{
"question": "Should opioid analgesia be withheld until the diagnosis is established?",
"answer": "No. In adults with undifferentiated acute abdominal pain, randomized-trial evidence summarized in a meta-analysis found opioid analgesia improved comfort without increasing diagnostic or treatment-decision errors.[12]"
},
{
"question": "What defines an acute abdomen requiring urgent surgical evaluation?",
"answer": "The key concern is rapidly evolving abdominal pathology with physiologic instability, peritoneal findings, obstruction, ischemia, hemorrhage, or another process likely to require urgent intervention. Severe, persistent symptoms require close monitoring and thorough investigation.[12][16]"
},
{
"question": "When should imaging be escalated in immunocompromised patients?",
"answer": "Use a lower threshold for hospital admission and cross-sectional imaging because immunocompromised patients may have nonspecific symptoms and an inconclusive examination despite significant pathology.[12]"
},
{
"question": "Can uncomplicated diverticulitis be managed without antibiotics?",
"answer": "Selected immunocompetent, clinically stable patients with uncomplicated disease can be managed initially without antibiotics; use antibiotics for higher-risk patients with comorbidity, immunosuppression, or systemic infection.[24]"
}
],
"references": [
{
"number": 1,
"title": "These highlights do not include all the information needed to use ONDANSETRON TABLETS safely and effectively. See full prescribing information for ONDANSETRON TABLETS.
ONDANSETRON tablets, for oral use
Initial U.S. Approval: 1991",
"detail": "nctr-crs.fda.gov",
"url": "https://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/3a79fc2b-9ea3-a808-e063-6394a90ae794/spl-doc?hl=",
"authors": "nctr-crs.fda.gov",
"host": "nctr-crs.fda.gov"
},
{
"number": 2,
"title": "Dosage and Administration Section of Labeling for Human ...",
"detail": "www.fda.gov",
"url": "https://www.fda.gov/media/72142/download",
"authors": "www.fda.gov",
"host": "www.fda.gov"
},
{
"number": 3,
"title": "FDA Approves Drug with New Mechanism of Action for Treatment of Schizophrenia | FDA",
"detail": "www.fda.gov",
"url": "https://www.fda.gov/news-events/press-announcements/fda-approves-drug-new-mechanism-action-treatment-schizophrenia",
"authors": "www.fda.gov",
"host": "www.fda.gov"
},
{
"number": 4,
"title": "JUXTAPID® (lomitapide) capsules, for oral use",
"detail": "www.accessdata.fda.gov",
"url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/203858s027lbl.pdf",
"authors": "www.accessdata.fda.gov",
"host": "www.accessdata.fda.gov"
},
{
"number": 5,
"title": "These highlights do not include all the information needed to use SUBOXONE sublingual film safely and effectively. See full prescribing information for SUBOXONE sublingual film.
SUBOXONE® (buprenorphine and naloxone) sublingual film, for sublingual or buccal use, CIII
Initial U.S. Approval: 2002",
"detail": "nctr-crs.fda.gov",
"url": "https://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/8a5edcf9-828c-4f97-b671-268ab13a8ecd/spl-doc?hl=",
"authors": "nctr-crs.fda.gov",
"host": "nctr-crs.fda.gov"
},
{
"number": 6,
"title": "These highlights do not include all the information needed to use FIRAZYR® (icatibant) safely and effectively. See full prescribing information for FIRAZYR.
\n
FIRAZYR (icatibant) Injection, for subcutaneous use
Initial U.S. Approval: 2011",
"detail": "www.accessdata.fda.gov",
"url": "https://www.accessdata.fda.gov/spl/data/59a20124-1c8d-4f0e-9932-1c574cdc6f45/59a20124-1c8d-4f0e-9932-1c574cdc6f45.xml",
"authors": "www.accessdata.fda.gov",
"host": "www.accessdata.fda.gov"
},
{
"number": 7,
"title": "MOUNJARO (tirzepatide) injection, for subcutaneous use",
"detail": "www.accessdata.fda.gov",
"url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/215866s009lbl.pdf",
"authors": "www.accessdata.fda.gov",
"host": "www.accessdata.fda.gov"
},
{
"number": 8,
"title": "Acute Abdominal Pain | Patient Information",
"detail": "jamanetwork.com",
"url": "https://jamanetwork.com/journals/jama/fullarticle/203608",
"authors": "jamanetwork.com",
"host": "jamanetwork.com"
},
{
"number": 9,
"title": "Acute Appendicitis | Gastroenterology",
"detail": "jamanetwork.com",
"url": "https://jamanetwork.com/journals/jama/fullarticle/2787114",
"authors": "jamanetwork.com",
"host": "jamanetwork.com"
},
{
"number": 10,
"title": "Validation and Refinement of a Prediction Rule to Identify ...",
"detail": "jamanetwork.com",
"url": "https://jamanetwork.com/journals/jamapediatrics/fullarticle/1263344",
"authors": "jamanetwork.com",
"host": "jamanetwork.com"
},
{
"number": 11,
"title": "Decreased Use of Computed Tomography With a Modified ...",
"detail": "jamanetwork.com",
"url": "https://jamanetwork.com/journals/jamasurgery/fullarticle/406568",
"authors": "jamanetwork.com",
"host": "jamanetwork.com"
},
{
"number": 12,
"title": "Evaluation of acute abdomen - Differential diagnosis of symptoms | BMJ Best Practice US",
"detail": "bestpractice.bmj.com",
"url": "https://bestpractice.bmj.com/topics/en-us/503",
"authors": "bestpractice.bmj.com",
"host": "bestpractice.bmj.com"
},
{
"number": 13,
"title": "2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the ...",
"detail": "www.ahajournals.org",
"url": "https://www.ahajournals.org/doi/10.1161/CIR.0000000000001168",
"authors": "www.ahajournals.org",
"host": "www.ahajournals.org"
},
{
"number": 14,
"title": "2026 Guideline for the Early Management of Patients With ...",
"detail": "www.ahajournals.org",
"url": "https://www.ahajournals.org/doi/10.1161/STR.0000000000000513",
"authors": "www.ahajournals.org",
"host": "www.ahajournals.org"
},
{
"number": 15,
"title": "Current status of the diagnosis and treatment of acute abdomen and analysis of risk factors for prognosis: Experience in the emergency department of a single center in Pemba, Tanzania",
"detail": "www.sciencedirect.com",
"url": "https://www.sciencedirect.com/science/article/pii/S0011384025000735",
"authors": "www.sciencedirect.com",
"host": "www.sciencedirect.com"
},
{
"number": 16,
"title": "Acute Abdomen - an overview",
"detail": "www.sciencedirect.com",
"url": "https://www.sciencedirect.com/topics/medicine-and-dentistry/acute-abdomen",
"authors": "www.sciencedirect.com",
"host": "www.sciencedirect.com"
},
{
"number": 17,
"title": "FINE-CATHETER ASPIRATION CYTOLOGY OF ...",
"detail": "www.sciencedirect.com",
"url": "https://www.sciencedirect.com/science/article/abs/pii/S0140673686927315",
"authors": "www.sciencedirect.com",
"host": "www.sciencedirect.com"
},
{
"number": 18,
"title": "GLIM‐defined malnutrition in patients with acute abdomen ...",
"detail": "aspenjournals.onlinelibrary.wiley.com",
"url": "https://aspenjournals.onlinelibrary.wiley.com/doi/10.1002/ncp.11202",
"authors": "aspenjournals.onlinelibrary.wiley.com",
"host": "aspenjournals.onlinelibrary.wiley.com"
},
{
"number": 19,
"title": "Pediatric Acute Abdomen: Bread-and-Butter Diagnoses",
"detail": "www.sciencedirect.com",
"url": "https://www.sciencedirect.com/science/article/abs/pii/S0037198X24000208",
"authors": "www.sciencedirect.com",
"host": "www.sciencedirect.com"
},
{
"number": 20,
"title": "Practice Guidelines for Primary Care of Acute Abdomen 2015",
"detail": "onlinelibrary.wiley.com",
"url": "https://onlinelibrary.wiley.com/doi/10.1002/jhbp.303",
"authors": "onlinelibrary.wiley.com",
"host": "onlinelibrary.wiley.com"
},
{
"number": 21,
"title": "2024 CPDD Abstract Booklet - 2024 - Wiley Online Library",
"detail": "accp1.onlinelibrary.wiley.com",
"url": "https://accp1.onlinelibrary.wiley.com/doi/full/10.1002/cpdd.1459",
"authors": "accp1.onlinelibrary.wiley.com",
"host": "accp1.onlinelibrary.wiley.com"
},
{
"number": 22,
"title": "Clinical Policy: Critical Issues in the Evaluation of Adult ...",
"detail": "www.acep.org",
"url": "https://www.acep.org/siteassets/uploads/uploaded-files/acep/continuing-education/moc-resource-center/member-llsa-resources/acutebluntabdominaltrauma.pdf",
"authors": "www.acep.org",
"host": "www.acep.org"
},
{
"number": 23,
"title": "ABDOMINAL DISORDERS",
"detail": "www.acep.org",
"url": "https://www.acep.org/siteassets/sites/acep/media/event-course-proposals/sa_acepsa-courses.pdf",
"authors": "www.acep.org",
"host": "www.acep.org"
},
{
"number": 24,
"title": "Acute left-sided colonic diverticulitis: A surgeon’s perspective on the ACP guidelines | Cleveland Clinic Journal of medicine",
"detail": "www.ccjm.org",
"url": "https://www.ccjm.org/content/90/7/403",
"authors": "www.ccjm.org",
"host": "www.ccjm.org"
}
],
"editorialNote": "Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.",
"citations": [
{
"number": 1,
"title": "These highlights do not include all the information needed to use ONDANSETRON TABLETS safely and effectively. See full prescribing information for ONDANSETRON TABLETS.
ONDANSETRON tablets, for oral use
Initial U.S. Approval: 1991",
"detail": "nctr-crs.fda.gov",
"url": "https://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/3a79fc2b-9ea3-a808-e063-6394a90ae794/spl-doc?hl=",
"authors": "nctr-crs.fda.gov",
"host": "nctr-crs.fda.gov",
"snippet": "8.6 Hepatic Impairment No dosage adjustment is needed in patients with mild or moderate hepatic impairment. \n \n In patients with severe hepatic impairment, clearance is reduced and the apparent volume of distribution is increased, resulting in a significant increase in the half-life of ondanset",
"score": 0.38193452
},
{
"number": 2,
"title": "Dosage and Administration Section of Labeling for Human ...",
"detail": "www.fda.gov",
"url": "https://www.fda.gov/media/72142/download",
"authors": "www.fda.gov",
"host": "www.fda.gov",
"snippet": "the same term which is generally used in an interchangeable biosimilarity 666 statement in the Highlights of Prescribing Information of interchangeable biosimilar 667 products.92,93 For example, this section should not state that “drugoxide liposome injection and 668 drugoxide injection are not inte",
"score": 0.27135292
},
{
"number": 3,
"title": "FDA Approves Drug with New Mechanism of Action for Treatment of Schizophrenia | FDA",
"detail": "www.fda.gov",
"url": "https://www.fda.gov/news-events/press-announcements/fda-approves-drug-new-mechanism-action-treatment-schizophrenia",
"authors": "www.fda.gov",
"host": "www.fda.gov",
"snippet": "The prescribing information includes warnings that Cobenfy can cause urinary retention, increased heart rate, decreased gastric movement or angioedema (swelling beneath the skin) of the face and lips. Cobenfy is not recommended for patients with mild hepatic (liver) impairment. It should not be used",
"score": 0.26966324
},
{
"number": 4,
"title": "JUXTAPID® (lomitapide) capsules, for oral use",
"detail": "www.accessdata.fda.gov",
"url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/203858s027lbl.pdf",
"authors": "www.accessdata.fda.gov",
"host": "www.accessdata.fda.gov",
"snippet": "aged 9 years and older, or 200 IU for patients aged 2 to 8 years old] and linoleic acid (200 mg), alpha-linolenic acid (210 mg), eicosapentaenoic acid (110 mg), and docosahexaenoic acid (80 mg) supplements (2.2). • Take orally once daily, whole, with water and without food, at least 2 hours after ev",
"score": 0.22599728
},
{
"number": 5,
"title": "These highlights do not include all the information needed to use SUBOXONE sublingual film safely and effectively. See full prescribing information for SUBOXONE sublingual film.
SUBOXONE® (buprenorphine and naloxone) sublingual film, for sublingual or buccal use, CIII
Initial U.S. Approval: 2002",
"detail": "nctr-crs.fda.gov",
"url": "https://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/8a5edcf9-828c-4f97-b671-268ab13a8ecd/spl-doc?hl=",
"authors": "nctr-crs.fda.gov",
"host": "nctr-crs.fda.gov",
"snippet": "5.19 Effects in Acute Abdominal Conditions As with other opioids, buprenorphine may obscure the diagnosis or clinical course of patients with acute abdominal conditions.\n\n \n\n6 ADVERSE REACTIONS The following serious adverse reactions are described elsewhere in the labeling: [...] Hepatic Impairme",
"score": 0.20277487
},
{
"number": 6,
"title": "These highlights do not include all the information needed to use FIRAZYR® (icatibant) safely and effectively. See full prescribing information for FIRAZYR.
\n
FIRAZYR (icatibant) Injection, for subcutaneous use
Initial U.S. Approval: 2011",
"detail": "www.accessdata.fda.gov",
"url": "https://www.accessdata.fda.gov/spl/data/59a20124-1c8d-4f0e-9932-1c574cdc6f45/59a20124-1c8d-4f0e-9932-1c574cdc6f45.xml",
"authors": "www.accessdata.fda.gov",
"host": "www.accessdata.fda.gov",
"snippet": "Table 1 Adverse reactions observed in >1% of patients with acute attacks of HAE and at a higher rate with FIRAZYR versus placebo in the placebo-controlled trialsEvents occurring within 14 days of study drug administration",
"score": 0.19891903
},
{
"number": 7,
"title": "MOUNJARO (tirzepatide) injection, for subcutaneous use",
"detail": "www.accessdata.fda.gov",
"url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/215866s009lbl.pdf",
"authors": "www.accessdata.fda.gov",
"host": "www.accessdata.fda.gov",
"snippet": "safety or efficacy were detected between these patients and younger patients, but greater sensitivity of some older individuals cannot be ruled out. 8.6 Renal Impairment No dosage adjustment of MOUNJARO is recommended for patients with renal impairment. In subjects with renal impairment including en",
"score": 0.16636397
},
{
"number": 8,
"title": "Acute Abdominal Pain | Patient Information",
"detail": "jamanetwork.com",
"url": "https://jamanetwork.com/journals/jama/fullarticle/203608",
"authors": "jamanetwork.com",
"host": "jamanetwork.com",
"snippet": "by JL Zeller · 2006 · Cited by 12 — Acute abdominal pain has a sudden onset, can persist for several hours or days, and may be caused by a variety of conditions or diseases.",
"score": 0.28424355
},
{
"number": 9,
"title": "Acute Appendicitis | Gastroenterology",
"detail": "jamanetwork.com",
"url": "https://jamanetwork.com/journals/jama/fullarticle/2787114",
"authors": "jamanetwork.com",
"host": "jamanetwork.com",
"snippet": "by K Walter · 2021 · Cited by 42 — Diagnosis of acute appendicitis is made based on a patient's history, physical examination, laboratory values (such as a high white blood cell",
"score": 0.23588239
},
{
"number": 10,
"title": "Validation and Refinement of a Prediction Rule to Identify ...",
"detail": "jamanetwork.com",
"url": "https://jamanetwork.com/journals/jamapediatrics/fullarticle/1263344",
"authors": "jamanetwork.com",
"host": "jamanetwork.com",
"snippet": "by AB Kharbanda · 2012 · Cited by 78 — To validate and refine a clinical prediction rule to identify which children with acute abdominal pain are at low risk for appendicitis (Low-",
"score": 0.22296266
},
{
"number": 11,
"title": "Decreased Use of Computed Tomography With a Modified ...",
"detail": "jamanetwork.com",
"url": "https://jamanetwork.com/journals/jamasurgery/fullarticle/406568",
"authors": "jamanetwork.com",
"host": "jamanetwork.com",
"snippet": "by A Rezak · 2011 · Cited by 85 — Hypothesis Use of a modified clinical grading score improves accuracy in diagnosing acute appendicitis in the pediatric population while",
"score": 0.10787861
},
{
"number": 12,
"title": "Evaluation of acute abdomen - Differential diagnosis of symptoms | BMJ Best Practice US",
"detail": "bestpractice.bmj.com",
"url": "https://bestpractice.bmj.com/topics/en-us/503",
"authors": "bestpractice.bmj.com",
"host": "bestpractice.bmj.com",
"snippet": "An acute abdomen may occur as a result of immunosuppressive therapy. Typhlitis (neutropenic enterocolitis) is a complication of chemotherapy that typically presents with fever, neutropenia, and right iliac fossa pain 10 to 14 days after initiation of chemotherapy.(#referencePop12)Spencer SP, Power N",
"score": 0.45784017
},
{
"number": 13,
"title": "2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the ...",
"detail": "www.ahajournals.org",
"url": "https://www.ahajournals.org/doi/10.1161/CIR.0000000000001168",
"authors": "www.ahajournals.org",
"host": "www.ahajournals.org",
"snippet": "The recommendations listed in this guideline are, whenever possible, evidence based. An initial extensive evidence review—which included literature derived from research involving human subjects, published in English, and indexed in MEDLINE (through PubMed), EMBASE, the Cochrane Library, the Agency ",
"score": 0.122429006
},
{
"number": 14,
"title": "2026 Guideline for the Early Management of Patients With ...",
"detail": "www.ahajournals.org",
"url": "https://www.ahajournals.org/doi/10.1161/STR.0000000000000513",
"authors": "www.ahajournals.org",
"host": "www.ahajournals.org",
"snippet": "This updated guideline is intended to provide a comprehensive, up-to-date, evidence-based set of recommendations, advising management from",
"score": 0.056574304
},
{
"number": 15,
"title": "Current status of the diagnosis and treatment of acute abdomen and analysis of risk factors for prognosis: Experience in the emergency department of a single center in Pemba, Tanzania",
"detail": "www.sciencedirect.com",
"url": "https://www.sciencedirect.com/science/article/pii/S0011384025000735",
"authors": "www.sciencedirect.com",
"host": "www.sciencedirect.com",
"snippet": "intensity (VAS scores). Secondary outcomes included opioid consumption, neurological recovery (ASIA, JOA scores), functional outcomes (NDI), and quality of life measures. The intervention group demonstrated significantly lower VAS pain scores at all time points (p < 0.001), with 38.6% reduction in m",
"score": 0.64746445
},
{
"number": 16,
"title": "Acute Abdomen - an overview",
"detail": "www.sciencedirect.com",
"url": "https://www.sciencedirect.com/topics/medicine-and-dentistry/acute-abdomen",
"authors": "www.sciencedirect.com",
"host": "www.sciencedirect.com",
"snippet": "liver enzymes. None of these is invariably present and none is diagnostic for pancreatitis. In acute necrotizing pancreatitis, methaemalbuminaemia may be detectable. The main use of these tests is to provide information about the prognosis, and they may also influence management. Biochemical tests t",
"score": 0.5501488
},
{
"number": 17,
"title": "FINE-CATHETER ASPIRATION CYTOLOGY OF ...",
"detail": "www.sciencedirect.com",
"url": "https://www.sciencedirect.com/science/article/abs/pii/S0140673686927315",
"authors": "www.sciencedirect.com",
"host": "www.sciencedirect.com",
"snippet": "by RJ Stewart · 1986 · Cited by 32 — Current status of the diagnosis and treatment of acute abdomen and analysis of risk factors for prognosis: Experience in the emergency department of a single",
"score": 0.46482924
},
{
"number": 18,
"title": "GLIM‐defined malnutrition in patients with acute abdomen ...",
"detail": "aspenjournals.onlinelibrary.wiley.com",
"url": "https://aspenjournals.onlinelibrary.wiley.com/doi/10.1002/ncp.11202",
"authors": "aspenjournals.onlinelibrary.wiley.com",
"host": "aspenjournals.onlinelibrary.wiley.com",
"snippet": "GLIM-defined malnutrition in patients with acute abdomen associated with poor prognosis. The top three diagnoses of acute abdomen were",
"score": 0.39187187
},
{
"number": 19,
"title": "Pediatric Acute Abdomen: Bread-and-Butter Diagnoses",
"detail": "www.sciencedirect.com",
"url": "https://www.sciencedirect.com/science/article/abs/pii/S0037198X24000208",
"authors": "www.sciencedirect.com",
"host": "www.sciencedirect.com",
"snippet": "presenting with an acute abdomen must be evaluated with a meticulous history, physical exam, laboratory and radiologic testing. Imaging is an integral component of the workup and must be used judiciously, by selecting the appropriate modality for the age and possible diagnoses, understanding the ben",
"score": 0.37401357
},
{
"number": 20,
"title": "Practice Guidelines for Primary Care of Acute Abdomen 2015",
"detail": "onlinelibrary.wiley.com",
"url": "https://onlinelibrary.wiley.com/doi/10.1002/jhbp.303",
"authors": "onlinelibrary.wiley.com",
"host": "onlinelibrary.wiley.com",
"snippet": "The causes of acute abdomen are classified into (1) localized abdominal pain; (2) clinical conditions, such as inflammation and/or infection,",
"score": 0.23773557
},
{
"number": 21,
"title": "2024 CPDD Abstract Booklet - 2024 - Wiley Online Library",
"detail": "accp1.onlinelibrary.wiley.com",
"url": "https://accp1.onlinelibrary.wiley.com/doi/full/10.1002/cpdd.1459",
"authors": "accp1.onlinelibrary.wiley.com",
"host": "accp1.onlinelibrary.wiley.com",
"snippet": "suggesting no dose adjustments are required for rusfertide in patients with severe renal impairment or with moderate hepatic impairment.",
"score": 0.2475465
},
{
"number": 22,
"title": "Clinical Policy: Critical Issues in the Evaluation of Adult ...",
"detail": "www.acep.org",
"url": "https://www.acep.org/siteassets/uploads/uploaded-files/acep/continuing-education/moc-resource-center/member-llsa-resources/acutebluntabdominaltrauma.pdf",
"authors": "www.acep.org",
"host": "www.acep.org",
"snippet": "Recommendations offered in this policy are not intended to represent the only diagnostic and management options that the emergency physician should consider. ACEP clearly recognizes the importance of the individual physician’s judgment. Rather, this guideline defines for the physician those strategie",
"score": 0.65914243
},
{
"number": 23,
"title": "ABDOMINAL DISORDERS",
"detail": "www.acep.org",
"url": "https://www.acep.org/siteassets/sites/acep/media/event-course-proposals/sa_acepsa-courses.pdf",
"authors": "www.acep.org",
"host": "www.acep.org",
"snippet": "To HINTS or Not to HINTS: A Tale of 2 Guidelines: ACEP Connect Bruce M. Lo, MD, MBA, RDMS, FACEP; Jonathan Edlow, MD Evaluating the dizzy patient can present challenging even for the most seasoned physician. Two recent clinical ED guidelines (ACEP and SAEM) have approached this topic with what appea",
"score": 0.42391166
},
{
"number": 24,
"title": "Acute left-sided colonic diverticulitis: A surgeon’s perspective on the ACP guidelines | Cleveland Clinic Journal of medicine",
"detail": "www.ccjm.org",
"url": "https://www.ccjm.org/content/90/7/403",
"authors": "www.ccjm.org",
"host": "www.ccjm.org",
"snippet": "Other publications\n\n## Umbrella menu\n\nlogo\nlogo\n\n## Main navigation\n\nlogo\nlogo\n\n# Acute left-sided colonic diverticulitis: A surgeon’s perspective on the ACP guidelines\n\nThe updated guidelines on the management of acute left-sided colonic diverticulitis from the American College of Physicians (ACP),",
"score": 0.34343034
}
],
"publishedAt": "2026-08-20T23:31:42.514853Z",
"updatedAt": "2026-08-20T23:31:42.514853Z",
"readingMinutes": 5,
"slug": "acute-abdomen"
}